Novel biomarkers enable new rapid test for preeclampsia

Preeclampsia is a potentially deadly condition that affects 4% to 8% of pregnant women worldwide, but the condition can be difficult to diagnose. Now, a team of Australian researchers has developed a quick and accurate new test using nanoparticle-based technology and novel biomarkers.